Free Trial

JPMorgan Claverhouse (LON:JCH) Hits New 1-Year High - Here's Why

JPMorgan Claverhouse logo with Financial Services background

JPMorgan Claverhouse (LON:JCH - Get Free Report)'s stock price hit a new 52-week high during trading on Friday . The stock traded as high as GBX 762 ($10.13) and last traded at GBX 758 ($10.08), with a volume of 87685 shares trading hands. The stock had previously closed at GBX 746 ($9.92).

JPMorgan Claverhouse Stock Up 1.3 %

The firm has a 50 day moving average of GBX 727.61 and a 200 day moving average of GBX 717.47. The company has a quick ratio of 67.67, a current ratio of 0.71 and a debt-to-equity ratio of 11.85. The firm has a market cap of £423.60 million, a price-to-earnings ratio of 7.33 and a beta of 0.83.

JPMorgan Claverhouse (LON:JCH - Get Free Report) last issued its quarterly earnings data on Friday, March 21st. The investment trust reported GBX 30.15 ($0.40) earnings per share (EPS) for the quarter. JPMorgan Claverhouse had a net margin of 92.61% and a return on equity of 14.30%.

JPMorgan Claverhouse Cuts Dividend

The business also recently announced a dividend, which will be paid on Wednesday, July 2nd. Shareholders of record on Thursday, May 22nd will be paid a GBX 8.40 ($0.11) dividend. The ex-dividend date of this dividend is Thursday, May 22nd. This represents a dividend yield of 1.23%. JPMorgan Claverhouse's dividend payout ratio (DPR) is currently 33.69%.

About JPMorgan Claverhouse

(Get Free Report)

Great British dividends The JPMorgan Claverhouse Investment Trust has been helping investors tap directly into the long-term growth potential of UK large cap stocks since 1963. The trust focuses on attractively valued, high quality stocks with the ability to generate consistent and growing dividends. Key points Expertise • Managed by an investment team with long-standing UK equity experience, backed by the extensive resources of J.P.

Featured Stories

Should You Invest $1,000 in JPMorgan Claverhouse Right Now?

Before you consider JPMorgan Claverhouse, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and JPMorgan Claverhouse wasn't on the list.

While JPMorgan Claverhouse currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 AI ETFs for Steady Gains in 2025 (Without the Wild Volatility)
Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines